3.15
급성 호흡 부전 치료는 근본 원인, 전반적인 건강 상태, 심각도와 같은 요인에 따라 다릅니다. 협력 의료팀은 종종 동맥혈 가스 분석을 통해 조기에 발견하는 데 필수적입니다. 원인을 식별하는 것이 주요 목표이며, 치료 전략은 환기/관류(V/Q) 불일치, 단락 또는 확산…
급성 호흡 부전을 관리하려면 협력적 접근 방식이 필요합니다.
호흡기 치료는 산소화와 환기를 최적화하는 동시에 산-염기 불균형을 해결하는 것을 목표로 합니다.
호흡 부전의 중증도에 맞게 산소 투여를 조정하고, 비강 캐뉼라 또는 벤투리 마스크와 같은 저유량 장치부터 시작합니다. 그러나 반응이 없는 환자는 기계적 환기가 필요할 수 있습니다.
다음으로, 약물 요법에는 기관지 경련과 염증을 완화하기 위해 코르티코스테로이드를 정맥 주사하는 속효성 기관지 확장제가 포함됩니다. 폐 울혈을 완화하기 위해 정맥 주사로 이뇨제를 투여하고, 감염을 막기 위해 항생제를 투
여합니다.격렬한 기침, 흉부 물리 치료, 필요한 경우 흡입과 같은 기술을 사용하여 남아 있는 폐 분비물을 효과적으로 동원하십시오.
또한 분무기를 통해 멸균된 생리 식염수 또는 점액 용해제의 에어로졸을 사용하는 가습은 분비물 관리에 도움이 됩니다.
금기 사항이 아닌 한 매일 2-3리터의 수분을 섭취하여 분비물을 묽게 유지하고 쉽게 제거할 수 있습니다.
마지막으로, 영양 지원에는 칼로리 요구량을 결정하고 회복을 위한 적절한 단백질, 탄수화물, 지방 및 비타민 섭취를 보장하는 것이 포함됩니다.
View the full transcript and gain access to JoVE Core videos
Q1: What oxygen delivery methods are used to treat acute respiratory failure?
Oxygen therapy begins with low-flow devices like nasal cannulas at 1-2 L/min or Venturi masks at 24-28% oxygen concentration for responsive patients. Unresponsive patients or those with severe hypoxemia require mechanical ventilation with higher oxygen concentrations. Device selection depends on the patient's respiratory status, ability to maintain an open airway, and capacity to breathe spontaneously.
Q2: How do bronchodilators and corticosteroids help manage acute respiratory failure?
Short-acting bronchodilators relax lung muscles and expand airways, promoting easier breathing and improved respiratory function. Intravenous corticosteroids reduce airway inflammation and bronchospasm. Together, these medications address the underlying airway obstruction and inflammatory response, facilitating better oxygenation and ventilation in acute respiratory failure.
Q3: What techniques mobilize retained secretions in respiratory failure patients?
Effective secretion management combines vigorous coughing, chest physiotherapy with percussion and vibration, and suctioning through nasal or oral catheters. Humidification using aerosols of sterile normal saline or mucolytic drugs via nebulizer prevents secretion drying. Adequate hydration of 2-3 liters daily thins secretions, facilitating removal and promoting ciliary clearance.
Q4: Why is nutritional support critical in acute respiratory failure management?
Adequate nutrition supports immune function, wound healing, and preserves respiratory muscle strength. Calorie intake must be personalized to avoid overfeeding, which increases carbon dioxide production and oxygen consumption. Sufficient protein prevents muscle wasting, while micronutrients like Vitamin C, Vitamin D, Zinc, and Selenium enhance immune response and recovery.
Q5: What role do antibiotics and diuretics play in treating acute respiratory failure?
Antibiotics combat bacterial infections that may cause or complicate acute respiratory failure. Intravenous diuretics alleviate pulmonary congestion by eliminating excess fluid in the lungs, improving oxygenation and ventilation. Drug selection depends on identifying the underlying cause and addressing specific infection types or fluid overload conditions.
Q6: How does continuous monitoring guide treatment decisions in acute respiratory failure?
Continuous monitoring tracks respiratory status changes, arterial blood gas trends, and clinical improvement signs. Arterial blood gas analysis identifies acid-base imbalances and hypoxemia severity, guiding oxygen therapy adjustments. Collaborative healthcare teams use this data to tailor respiratory support, drug therapy, and interventions based on patient response.
Q7: What preventive nursing strategies support acute respiratory failure recovery?
Positioning patients upright or in tripod position promotes airflow and secretion drainage. Early ambulation when feasible enhances respiratory function and prevents complications. Proper patient positioning, combined with techniques from pneumonia nursing management and prevention, reduces infection risk and supports overall recovery in acute respiratory failure.